Table 7.
Breakdown of Neuro-ophthalmic Diagnoses. Excludes Pharmacovigilance or Observational Trials That Do Not Include Details of the Patients
| Neuro-ophthalmic primary diagnosis | N | % of Total (n=109) |
| Optic neuritis | 14 | 12.8 |
| Neuroretinitis | 1 | 0.9 |
| Myasthenia gravis* | 49 | 45.0 |
| Lambert-Eaton myasthenic syndrome gravis* | 1 | 0.9 |
| Orbital myositis | 15 | 13.8 |
| Thyroid-like eye disease | 13 | 11.9 |
| Giant cell arteritis | 4 | 3.7 |
| General myositis* | 8 | 7.3 |
| Internuclear ophthalmoplegia | 1 | 0.9 |
| opsoclonus-myoclonus-ataxia syndrome | 1 | 0.9 |
| Oculomotor nerve palsy | 1 | 0.9 |
Note: *With ocular involvement.